Members of the public who are listening to the meeting and wish to make a comment will have the opportunity to do so by doing the following: Once we have called for public comment, members of the ...

Members of the public who are listening to the meeting and wish to make a comment will have the opportunity to do so by doing the following: Once we have called for public comment, members of the ...

South San Francisco, CA, August 30, 2024 – The California Institute for Regenerative Medicine, one of the world’s largest institutes dedicated to regenerative medicine, approved $67.5 million to ...

Un premio de 12 millones de dólares a un equipo de investigadores dirigido por Alex Pollen, PhD, profesor adjunto de Neurología en la Universidad de California, San Francisco (UCSF), permitirá la ...

Our Agency funds clinical trials testing promising stem cell or gene therapies for currently incurable diseases or disorders to help patients with unmet medical needs. For basic information about stem ...

Our symposium brought together leaders in the field of biomaterials and tissue engineering. This 3 day symosium attracted over 300 attendees, many of which are graduate students and postdoc fellows.

RNA interference is a naturally occurring means to block the function of genes in our body. We propose that RNA interference can be used to block HIV-1 infection and its reproduction within the body.

This project led to the engineering of a humanized monoclonal antibody that targets a human protein (ENPP1) for treatment of myocardial infarction (heart attack). The project resulted in a successful ...

Cell-based cancer immunotherapy has revolutionized the treatment of hematological malignancies. Specifically, autologous chimeric antigen receptor-engineered T (CAR-T) cell therapies have received ...

胚胎干细胞在再生医学中的前景是基于它们具有制造体内每个细胞的潜力，这种特性被称为多能性。 随着技术的快速进步，从成体组织中制备胚胎干细胞样系变得相对简单。 在不久的将来 ...

开发实体肿瘤 CAR-T 细胞疗法的一个重要挑战是找到肿瘤中大量存在但在健康组织中并不丰富的表面蛋白。在这项研究中，我们确定了一种名为 TYRP1 的蛋白质，它是 CAR-T 细胞疗法的潜在靶点 ...

Un nouveau type d'APC sert les patients âgés en 1) améliorant le CSM en immunomodulation (réduction de l'inflammation) pour la transplantation autologue ; 2) une meilleure source de cellules ...